San-Miguel, JF Hungria, VTM Yoon, S-S Beksac, M Dimopoulos, MA Elghandour, A Jedrzejczak, WW Guenther, A Nakorn, TN Siritanaratkul, N others, Impact of treatment duration and dosing on efficacy and safety in a phase 3 study of panobinostat plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma, Clinical Lymphoma Myeloma and Leukemia, (15), e270--e271, 2015, Elsevier,